UK markets open in 51 minutes

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.87-1.42 (-6.10%)
At close: 04:00PM EDT
21.87 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121312
Avg. Estimate-0.16-0.63-2.67-2.66
Low estimate-0.95-0.95-4.07-3.98
High estimate3.27-0.24-1.26-1.46
Year ago EPS0.45-0.96-1.92-2.67
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10111313
Avg. Estimate63.87M29.52M139.03M156.01M
Low estimateN/AN/A53.55MN/A
High estimate250M75.5M302M286.1M
Year ago salesN/AN/A240.74M139.03M
Sales growth (year/est)N/AN/A-42.20%12.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.64-0.65-0.6-0.82
Actual EPS0.45-0.96-1.02-1.24
Difference1.09-0.31-0.42-0.42
Surprise %170.30%-47.70%-70.00%-51.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.16-0.63-2.67-2.66
7 days ago-0.16-0.63-2.67-2.63
30 days ago-0.16-0.63-2.67-2.63
60 days ago-0.16-0.63-2.67-2.63
90 days ago-0.39-0.83-3.25-3.24
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesARWRIndustrySector(s)S&P 500
Current qtr.-135.60%N/AN/AN/A
Next qtr.34.40%N/AN/AN/A
Current year-39.10%N/AN/AN/A
Next year0.40%N/AN/AN/A
Next 5 years (per annum)7.33%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A